The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...
The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic. HealthDay News — A new malaria treatment has been approved for newborns and ...
The partnership with Runway Health commences April 2, 2026. It adds a new platform to the 60 Degrees Pharma ARAKODA marketing strategy, where eligible users can match their travel itinerary with a ...
A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...
A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by making a drug that has been around since the 1970s last longer. Working ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. US Army hypersonic missile ...
New research shows the malaria parasite could be developing resistance to the current front-line treatment for the disease — a drug that has saved millions of lives. An anti-malaria drug that has ...
Researchers on Wednesday reported two promising new approaches to counteract malaria's growing resistance to medication -- one involving a new class of drugs. Switzerland-based Novartis released ...
Partnership adds a travel-focused consumer telehealth platform to the ARAKODA® marketing strategy, offering a new convenience to people planning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback